Recursion Pharmaceuticals, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Mubadala Investment Company affiliates have significantly reduced their beneficial ownership in Recursion Pharmaceuticals, Inc. to approximately 1.9% of outstanding shares, marking an exit for some entities.